| Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial M Valgimigli, G Campo, M Monti, P Vranckx, G Percoco, C Tumscitz, ... Circulation 125 (16), 2015-2026, 2012 | 821 | 2012 |
| Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial M Sabate, A Cequier, A Iñiguez, A Serra, R Hernandez-Antolin, V Mainar, ... The Lancet 380 (9852), 1482-1490, 2012 | 537 | 2012 |
| Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: the international multicenter FAVOR pilot study S Tu, J Westra, J Yang, C von Birgelen, A Ferrara, M Pellicano, H Nef, ... Cardiovascular Interventions 9 (19), 2024-2035, 2016 | 492 | 2016 |
| Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: relationship with gene polymorphisms and … G Campo, G Parrinello, P Ferraresi, B Lunghi, M Tebaldi, M Miccoli, ... Journal of the American College of Cardiology 57 (25), 2474-2483, 2011 | 415 | 2011 |
| Diagnostic performance of in‐procedure angiography‐derived quantitative flow reserve compared to pressure‐derived fractional flow reserve: the FAVOR II Europe‐Japan study J Westra, BK Andersen, G Campo, H Matsuo, L Koltowski, A Eftekhari, ... Journal of the American Heart Association 7 (14), e009603, 2018 | 336 | 2018 |
| Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. BC Valgimigli M, Patialiakas A, Thury A, McFadden E, Colangelo S, Campo G ... J Am Coll Cardiol. 65 (8), 805.15, 2015 | 302 | 2015 |
| Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a … M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ... The Lancet 392 (10150), 835-848, 2018 | 278 | 2018 |
| Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction … M Valgimigli, M Tebaldi, G Campo, S Gambetti, L Bristot, M Monti, ... JACC: Cardiovascular Interventions 5 (3), 268-277, 2012 | 195 | 2012 |
| Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials M Valgimigli, G Biondi-Zoccai, M Tebaldi, AWJ van't Hof, G Campo, ... European Heart Journal 31 (1), 35-49, 2010 | 186 | 2010 |
| Is bare-metal stent implantation still justifiable in high bleeding risk patients undergoing percutaneous coronary intervention? A pre-specified analysis from the ZEUS trial S Ariotti, M Adamo, F Costa, A Patialiakas, C Briguori, A Thury, ... JACC: Cardiovascular Interventions 9 (5), 426-436, 2016 | 167 | 2016 |
| Transradial coronary catheterization and intervention across the whole spectrum of Allen test results M Valgimigli, G Campo, C Penzo, M Tebaldi, S Biscaglia, R Ferrari, ... Journal of the American College of Cardiology 63 (18), 1833-1841, 2014 | 166 | 2014 |
| Two-year outcomes after first-or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre … M Valgimigli, M Tebaldi, M Borghesi, P Vranckx, G Campo, C Tumscitz, ... JACC: Cardiovascular interventions 7 (1), 20-28, 2014 | 160 | 2014 |
| Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment … M Valgimigli, M Borghesi, M Tebaldi, P Vranckx, G Parrinello, R Ferrari, ... European Heart Journal 34 (12), 909-919, 2013 | 135 | 2013 |
| Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study G Campo, M Valgimigli, D Gemmati, G Percoco, L Catozzi, A Frangione, ... Journal of the American College of Cardiology 50 (12), 1132-1137, 2007 | 127 | 2007 |
| Prognostic value of QFR measured immediately after successful stent implantation: the international multicenter prospective HAWKEYE study S Biscaglia, M Tebaldi, S Brugaletta, E Cerrato, A Erriquez, G Passarini, ... JACC: Cardiovascular Interventions 12 (20), 2079-2088, 2019 | 126 | 2019 |
| Quantitative flow ratio identifies nonculprit coronary lesions requiring revascularization in patients with ST-segment–elevation myocardial infarction and multivessel disease G Spitaleri, M Tebaldi, S Biscaglia, J Westra, S Brugaletta, A Erriquez, ... Circulation: Cardiovascular Interventions 11 (2), e006023, 2018 | 104 | 2018 |
| Evolving routine standards in invasive hemodynamic assessment of coronary stenosis: the nationwide Italian SICI-GISE cross-sectional ERIS study M Tebaldi, S Biscaglia, M Fineschi, G Musumeci, A Marchese, AM Leone, ... JACC: Cardiovascular Interventions 11 (15), 1482-1491, 2018 | 99 | 2018 |
| Randomized comparison of 6-versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary … M Valgimigli, G Campo, G Percoco, M Monti, F Ferrari, C Tumscitz, A Zuffi, ... American Heart Journal 160 (5), 804-811, 2010 | 91 | 2010 |
| Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis … R Pavasini, S Biscaglia, E Barbato, M Tebaldi, D Dudek, J Escaned, ... European heart journal 41 (42), 4103-4110, 2020 | 90 | 2020 |
| Radiation exposure and vascular access in acute coronary syndromes: the RAD-Matrix trial A Sciahbasi, E Frigoli, A Sarandrea, M Rothenbühler, P Calabrò, A Lupi, ... Journal of the American College of Cardiology 69 (20), 2530-2537, 2017 | 88 | 2017 |
Gianluca CampoU.O. Cardiologia, Azienda Ospedaliera di Ferrara在 unife.it 的电子邮件经过验证
